EXHIBIT 12.1
Ratio of Earnings to Fixed Charges | ||||||||||||||||||||||||
(dollars in thousands, except ratio data) | ||||||||||||||||||||||||
September 30, | December 31, | December 31, | December 31, | December 31, | December 31, | |||||||||||||||||||
2006 (5) | 2005 | 2004 | 2003 | 2002 | 2001 | |||||||||||||||||||
Fixed Charges: | ||||||||||||||||||||||||
Interest expense on indebtedness (including amortization of debt expense and discount) | $ | 19,410 | $ | 17,849 | $ | 22,868 | $ | 23,723 | $ | 23,746 | $ | 24,638 | ||||||||||||
Interest expense on portion of rent expense representative of interest | 14,731 | 14,614 | 9,089 | 7,604 | 7,206 | 6,159 | ||||||||||||||||||
Total Fixed Charges | $ | 34,141 | $ | 32,463 | $ | 31,957 | $ | 31,327 | $ | 30,952 | $ | 30,797 | ||||||||||||
Earnings (Loss): | ||||||||||||||||||||||||
Net loss before provision for income taxes | $ | (184,229 | ) | $ | (239,439 | ) | $ | (242,898 | ) | $ | (185,324 | ) | $ | (219,716 | ) | $ | (117,152 | ) | ||||||
Fixed Charges per above | 34,141 | 32,463 | 31,957 | 31,327 | 30,952 | 30,797 | ||||||||||||||||||
Total Earnings (Loss) | $ | (150,088 | ) | $ | (206,976 | ) | $ | (210,941 | ) | $ | (153,997 | ) | $ | (188,764 | ) | $ | (86,355 | ) | ||||||
Ratio of Earnings to Fixed Charges | — | — | — | — | — | — | ||||||||||||||||||
Coverage deficiency (1)(2)(3)(4) | $ | (184,229 | ) | $ | (239,439 | ) | $ | (242,898 | ) | $ | (185,324 | ) | $ | (219,716 | ) | $ | (117,152 | ) | ||||||
(1) | The Company’s Coverage deficiency for 2006 includes a charge of $16,840 relating to lease termination costs associated with one of the Company’s facilities. | |
(2) | The Company’s Coverage deficiency for 2004 includes net charges of $12,975, relating to a $15,408 charge for restructuring partially offset by a gain recognized on the extinguishment of debt of $2,433. | |
(3) | The Company’s Coverage deficiency for 2002 includes charges aggregating $46,396 arising from the Company’s impairment charge relating to its investment in CAT and a charge for construction design changes of $32,158 and $14,238, respectively. | |
(4) | The Company’s Coverage deficiency for 2001 includes charges aggregating $26,208 arising from the Company’s impairment charge relating to its investment in Transgene and debt conversion expenses of $22,314 and $3,894, respectively. | |
(5) | Amounts presented are for the nine months ended September 30, 2006. |